CAS: 3747-74-8; 2-(Chloromethyl)Quinoline Hydrochloride

该化合物是一种化学化合物,其特征是其quinoline结构,这是一种双环芳烃化合物,在异环环中含有氮原子,该物质一般是白色的,可脱白晶体固态,在水和各种有机溶剂中溶解,在各种化学应用中有用;该氯甲基组的存在增强了其反应性,允许其参与可在有机合成中使用的核生殖替代反应.作为盐,它通常比其自由基质形式更稳定,更容易处理.该化合物对医学化学感兴趣,并可能展示生物活动,尽管具体的药理特性取决于进一步的研究.安全数据表明,应谨慎地处理该物质,因为吸入或摄入可能会对健康造成危害,在实验室使用时应采取适当的安全措施.

结构式图片

相似化合物

22989-38-4 5632-15-5 4377-41-7

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号91-63-4 2-甲基喹啉 | CAS号105326-63-4 N-[4-(2-喹啉甲氧基)苯基]乙酰胺 | CAS号4377-41-7 2-(氯甲基)喹啉 | CAS号956750-61-1 2-((4-iodopheno... | CAS号5470-96-2 2-喹啉甲醛 | CAS号101910-24-1 L-655238 | CAS号137941-92-5 N-[4-[3-[methyl... | CAS号136727-11-2 N-methyl-1-quin... | CAS号1780-17-2 2-喹啉基甲醇 | CAS号120128-20-3 RG-12525 | CAS号651330-97-1 diethyl 2,2-bis...

合成工艺路线路线简述

    2-甲基喹啉置于sodium Carbonate Decahydrate,Sodium Carbonate,氯,盐酸体系中,用 水 用作溶剂,化学反应 3.0H,以267.8 G的收率获得2-氯甲基喹啉盐酸盐
    参考文献:The Process Development Of Rg 12525 (2-{[4-(Tetrazol-5-Ylmethylphenyl)-Methoxy]Phenoxymethyl}Quinoline)
    标题:The Process Development Of Rg 12525 (2-{[4-(Tetrazol-5-Ylmethylphenyl)-Methoxy]Phenoxymethyl}Quinoline)
    摘要:This Contribution Describes Process Improvements To Provide A Practical And Cost Effective Synthesis For The Manufacture Of Rg 12525 Which Resulted In A 3-Fold Increase In Overall Yield. Improved Solvent Systems For Chlorination And Azidation Reactions Are Described. Adjustments To The Tetrazole-Forming Step Eliminated Azide Sublimation And Minimised This Risk On Scaleup. A Robust Solvent System Was Found To Control The Polymorphic Form During Crystallisation,Which Had Hitherto Been Difficult Due To The Near-Equivalence Of Melting Points (154 And 157 Degreesc) Of The Two Known Forms.
    Doi:10.1021/op0000677

    海关参考信息

    专利信息


    专利号:US-12275733-B2
    优先权日:2016-11-07
    标 题:Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders
    发明人:GRETZKE DIRK; RITZELER OLAF; HEINELT UWE; WEHNER VOLKMAR; SCHMIDT FRIEDEMANN
    权利人:SANOFI SA
    摘要:The present invention relates to 8-aryl-substituted and 8-heteroaryl-substituted 9H-pyrido[3,4-b]indoles of the formula (I), in which A, E, G, R1 to R6 and R10 are as defined in the claims, which stimulate chondrogenesis and cartilage matrix synthesis and can be used in the treatment of cartilage disorders and conditions in which a regeneration of damaged cartilage is desired, for example joint diseases such as osteoarthritis. The invention furthermore relates to processes for the synthesis of the compounds of the formula (I), their use as pharmaceuticals, and pharmaceutical compositions comprising them.

    专利号:US-9040553-B2
    优先权日:2010-09-17
    标题:Phenoxyisobutyric acid compounds and method of synthesis
    发明人:LALEZARI IRAJ; FABRICANT JILL
    权利人:LALEZARI IRAJ; FABRICANT JILL; CELL VIABLE CORP
    摘要:The present invention provides a process for the synthesis of substituted phenoxymethylpropionic acid and related compounds. The compounds are useful for inhibiting the formation of AGEs (Advanced Glycation End Products).

    专利号:US-6166031-A
    优先权日:1987-10-19
    标 题:Substituted tetralins, chromans and related compounds in the treatment of asthma
    发明人:EGGLER JAMES F; MARFAT ANTHONY; MELVIN JR LAWRENCE S
    权利人:PFIZER
    摘要:Substituted tetralins, chromans and related compounds which, by inhibiting 5-lipoxygenase enzyme and/or blocking leukotriene receptors, are useful in the prevention or treatment of asthma, arthritis, psoriasis, ulcers, myocardial infarction and related disease states in mammals; pharmaceutical compositions comprising said compounds; a method of treatment with said compounds; and intermediates useful in the synthesis of said compounds.

    专利号:US-11976052-B2
    优先权日:2019-01-11
    标题:Leukotriene synthesis inhibitors
    发明人:BURGOYNE DAVID L; DEBRUIN ERIN; FONAREV JULIA; YEE JAMES GEE KEN; LANGLANDS JOHN MICHAEL
    权利人:NAEGIS PHARMACEUTICALS INC
    摘要:Provided are specific leukotriene synthesis inhibitor compounds and pharmaceutical compositions comprising the compounds and methods of using the compounds and the pharmaceutical compositions in treating, for example, inflammatory diseases or conditions.

    专利号:US-10111854-B2
    优先权日:2014-02-26
    标题 :Synthesis and use of amine-containing flavonoids as potent anti-leishmanial agents
    发明人:CHOW LARRY MING-CHEUNG; Chan Tak Hang William; CHAN KIN-FAI; WONG IRIS LAI KING; KAN WING-YIU
    权利人:UNIV HONG KONG POLYTECHNIC
    摘要:The present invention relates to novel series of amine-containing flavonoids and compositions containing the compounds, as well as the synthesis and the use of the same. The invention also relates to methods of treatment and prevention of diseases, in particular, parasitic infections including Leishmaniasis, comprising administration of the compounds.

    专利号:US-8378099-B2
    优先权日:1994-10-28
    标 题:Boronic ester and acid compounds, synthesis and uses
    发明人:ADAMS JULIAN; MA YU-TING; STEIN ROSS L; BAEVSKY MATTHEW; GRENIER LOUIS; PLAMONDON LOUIS
    权利人:MILLENNIUM PHARMACUETICALS INC; ADAMS JULIAN; STEIN ROSS L; BAEVSKY MATTHEW; GRENIER LOUIS; PLAMONDON LOUIS
    摘要:Disclosed herein is a method for reducing the rate of degradation of proteins in an animal, comprising contacting cells of the animal with certain boronic ester and acid compounds. Also disclosed herein are novel boronic ester and acid compounds, their synthesis and uses.
    泰州志诚化工科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jszchg.com
    企业联系电话:0523-82837785;82833572;82832244👤
    📞泰州志诚化工科技有限公司 ⚠️参考联系方式
    联系人:赵经理
    电话:0523-82837785;82833572;82832244
    手机:13914525028
    传真:0523-87913272
    邮箱:sales@jszchg.com
    通信地址: 江苏省泰兴经济开发区城东工业园
    邮编: 225400
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省泰兴经济开发区城东工业园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    寿光市中和生物化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sgzhongheshengwu.com
    电话: 0536-5458969 13573635399👤
    📞寿光市中和生物化工有限公司 ⚠️参考联系方式

    销售电话:0536-5458969 13573635399
    邮箱:sales@zhonghepharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s00044-015-1330-z
    摘要:Wright BD, Deblock MC, Wagers PO, Duah E, Robishaw NK, Shelton KL, Southerland MR, DeBord MA, Kersten KM, McDonald LJ, Stiel JA, Panzner MJ, Tessier CA, Paruchuri S, Youngs WJ. Anti-tumor activity of lipophilic imidazolium salts on select NSCLC cell lines. Medicinal Chemistry Research. 2015 Feb 13;24(7):2838–61. doi: 10.1007/s00044-015-1330-z.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知